Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith S Kaye

Showing results (331-340 of 421) with videos related to

Pageof 43
Sort By:
Antimicrobial Agents and Chemotherapy|April 13, 2016
Epidemiology of Acute Kidney Injury among Patients Receiving Concomitant Vancomycin and Piperacillin-Tazobactam: Opportunities for Antimicrobial StewardshipShigehiko Karino, Keith S Kaye, Bhagyashri Navalkele, et al.
Antimicrobial Agents and Chemotherapy|July 20, 2016
Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream InfectionsKimberly C Claeys, Evan J Zasowski, Anthony M Casapao, et al.
Infection Control and Hospital Epidemiology|August 4, 2020
Deactivation of SARS-CoV-2 with pulsed-xenon ultraviolet light: Implications for environmental COVID-19 controlSarah E Simmons, Ricardo Carrion, Kendra J Alfson, et al.
American Journal of Infection Control|March 24, 2012
Retrospective evaluation of colistin versus tigecycline for the treatment of Acinetobacter baumannii and/or carbapenem-resistant Enterobacteriaceae infectionsKimberly Ku, Jason M Pogue, Judy Moshos, et al.
Scientific Reports|March 1, 2016
Global metabolic analyses identify key differences in metabolite levels between polymyxin-susceptible and polymyxin-resistant Acinetobacter baumanniiMohd Hafidz Mahamad Maifiah, Soon-Ee Cheah, Matthew D Johnson, et al.
Open Forum Infectious Diseases|February 18, 2016
Risk Factors and Outcomes for Carbapenem-Resistant Klebsiella pneumoniae Isolation, Stratified by Its Multilocus Sequence Typing: ST258 Versus Non-ST258Sorabh Dhar, Emily T Martin, Paul R Lephart, et al.
Infection Control and Hospital Epidemiology|December 22, 2015
Hospital Readmissions in Patients With Carbapenem-Resistant Klebsiella pneumoniaeJulia A Messina, Eric Cober, Sandra S Richter, et al.
Open Forum Infectious Diseases|November 29, 2017
Carbapenem-Resistant Enterobacteriaceae Infections in Patients on Renal Replacement TherapyBrandon Eilertson, Eric Cober, Sandra S Richter, et al.
American Journal of Infection Control|September 10, 2013
Risk factors for and epidemiology of community-onset vancomycin-resistant Enterococcus faecalis in southeast MichiganAdedayo Morenike Omotola, Yumeng Li, Emily T Martin, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 23, 2021
Assessing the predictive performance of population pharmacokinetic models for intravenous polymyxin B in critically ill patientsPatrick O Hanafin, Roger L Nation, Marc H Scheetz, et al.
Pageof 43

Showing results (331-340 of 421) with videos related to

Sort By:
Pageof 43
Antimicrobial Agents and Chemotherapy|April 13, 2016
Epidemiology of Acute Kidney Injury among Patients Receiving Concomitant Vancomycin and Piperacillin-Tazobactam: Opportunities for Antimicrobial StewardshipShigehiko Karino, Keith S Kaye, Bhagyashri Navalkele, et al.
Antimicrobial Agents and Chemotherapy|July 20, 2016
Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream InfectionsKimberly C Claeys, Evan J Zasowski, Anthony M Casapao, et al.
Infection Control and Hospital Epidemiology|August 4, 2020
Deactivation of SARS-CoV-2 with pulsed-xenon ultraviolet light: Implications for environmental COVID-19 controlSarah E Simmons, Ricardo Carrion, Kendra J Alfson, et al.
American Journal of Infection Control|March 24, 2012
Retrospective evaluation of colistin versus tigecycline for the treatment of Acinetobacter baumannii and/or carbapenem-resistant Enterobacteriaceae infectionsKimberly Ku, Jason M Pogue, Judy Moshos, et al.
Scientific Reports|March 1, 2016
Global metabolic analyses identify key differences in metabolite levels between polymyxin-susceptible and polymyxin-resistant Acinetobacter baumanniiMohd Hafidz Mahamad Maifiah, Soon-Ee Cheah, Matthew D Johnson, et al.
Open Forum Infectious Diseases|February 18, 2016
Risk Factors and Outcomes for Carbapenem-Resistant Klebsiella pneumoniae Isolation, Stratified by Its Multilocus Sequence Typing: ST258 Versus Non-ST258Sorabh Dhar, Emily T Martin, Paul R Lephart, et al.
Infection Control and Hospital Epidemiology|December 22, 2015
Hospital Readmissions in Patients With Carbapenem-Resistant Klebsiella pneumoniaeJulia A Messina, Eric Cober, Sandra S Richter, et al.
Open Forum Infectious Diseases|November 29, 2017
Carbapenem-Resistant Enterobacteriaceae Infections in Patients on Renal Replacement TherapyBrandon Eilertson, Eric Cober, Sandra S Richter, et al.
American Journal of Infection Control|September 10, 2013
Risk factors for and epidemiology of community-onset vancomycin-resistant Enterococcus faecalis in southeast MichiganAdedayo Morenike Omotola, Yumeng Li, Emily T Martin, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 23, 2021
Assessing the predictive performance of population pharmacokinetic models for intravenous polymyxin B in critically ill patientsPatrick O Hanafin, Roger L Nation, Marc H Scheetz, et al.
Pageof 43